Characteristic | Patients (n = 260) |
---|---|
Mean ± SD age, years | 48.9 ± 20 |
Males, n (%) | 149 (57.3) |
Comorbidities, n (%) | |
Diabetes mellitus | 12 (4.6) |
Obesity | 12 (4.6) |
Lifestyle factors, n (%) | |
Smoking | 27 (10.4) |
Alcoholism | 0 (0) |
Therapeutic failure risk factors, n (%) | |
Age > 65 years | 63 (24.2) |
Cancer | 16 (6.2) |
Anemia | 16 (6.2) |
Liver cirrhosis | 1 (0.4) |
Renal failure | 1 (0.4) |
Acute liver failure | 0 (0) |
End stage renal failure | 2 (0.8) |
Coagulopathy | 2 (0.8) |
Immunosuppression | 2 (0.8) |
Leukopenia | 0 (0) |
Primary surgical intervention site, n (%) | |
Appendix | 162 (62.3) |
Lower GI tract | 51 (19.6) |
Upper GI tract | 13 (5.0) |
Gall-bladder | 14 (5.4) |
Peritoneal abscess | 16 (6.1) |
Explorative laparotomy/laparoscopy | 4 (1.5) |
Surgical approach, n (%) | |
Laparoscopy | 135 (51.9) |
Laparotomy | 116 (44.6) |
Percutaneous | 9 (3.5) |
Illness severity markers, n (%) | |
Parenteral nutrition | 52 (20.0) |
Central venous catheter | 44 (16.9) |
Antifungal drugs | 28 (10.8) |
Enteral nutrition | 22 (8.4) |
Invasive mechanical ventilation | 20 (7.7) |
Immune globulins | 0 (0) |
Renal replacement therapies | 0 (0) |
ICU transfer, n (%) | 24 (9.2) |
Mean ± SD length of hospital stay, days | 10.4 ± 13 |
Mortality rate, n (%) | 6 (2.3) |